68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

被引:0
作者
Wojciech Cytawa
Anna Katharina Seitz
Stefan Kircher
Kazuhito Fukushima
Johannes Tran-Gia
Andreas Schirbel
Tomasz Bandurski
Piotr Lass
Markus Krebs
Wojciech Połom
Marcin Matuszewski
Hans-Jürgen Wester
Andreas K. Buck
Hubert Kübler
Constantin Lapa
机构
[1] Medical University of Gdańsk,Department of Nuclear Medicine
[2] University Hospital Würzburg,Department of Nuclear Medicine
[3] University Hospital Würzburg,Department of Urology
[4] University of Würzburg,Institute of Pathology, Comprehensive Cancer Center Mainfranken (CCCMF)
[5] Medical University of Gdańsk,Department of Radiology Informatics and Statistics
[6] Medical University of Gdansk,Department of Urology
[7] Technische Universität München,Pharmaceutical Radiochemistry
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2020年 / 47卷
关键词
Prostate cancer; PSMA; PET/CT; Primary staging; Ga-PSMA I&T;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:168 / 177
页数:9
相关论文
共 210 条
[1]  
Cetin Karynsa(2010)Recent Time Trends in the Epidemiology of Stage IV Prostate Cancer in the United States: Analysis of Data From the Surveillance, Epidemiology, and End Results Program* Urology 75 1396-1404
[2]  
Beebe-Dimmer Jennifer L.(2017)Prostate Cancer EAU Guidelines 2017 Eur Urol 17 618-629
[3]  
Fryzek Jon P.(2014)Removal of limited nodal disease in patients undergoing radical prostatectomy: long-term results confirm a chance for cure J Urol 191 1280-1285
[4]  
Markus Richard(2015)More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer Eur Urol 67 212-219
[5]  
Carducci Michael A.(2016)The rise of PSMA ligands for diagnosis and therapy of prostate cancer J Nucl Med 57 79S-89S
[6]  
Mottet N(2013)PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer Eur J Nucl Med Mol Imaging 40 1629-1630
[7]  
Bellmunt J(2014)Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer Eur J Nucl Med Mol Imaging 41 11-20
[8]  
Representative EBP(2016)Initial experience of 68Ga-PSMA PET/CT imaging in high-risk prostate cancer patients prior to radical prostatectomy Eur Urol 69 393-396
[9]  
Bolla M(2018)Efficacy, predictive factors, and prediction nomograms for (68)Ga-labeled prostate-specific membrane antigen-ligand positron-emission tomography/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy Eur Urol 73 656-661
[10]  
Bourke L(2018)(68)Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review World J Urol 36 519-527